DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 123 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,787,349 | +2.8% | 390,167 | 0.0% | 0.03% | -5.7% |
| Q2 2023 | $4,658,594 | +31.4% | 390,167 | +47.1% | 0.04% | +12.9% |
| Q1 2023 | $3,545,283 | +15.0% | 265,167 | +85.1% | 0.03% | -3.1% |
| Q4 2022 | $3,082,051 | +8.3% | 143,218 | +0.8% | 0.03% | -3.0% |
| Q3 2022 | $2,847,000 | -26.8% | 142,143 | -34.5% | 0.03% | -25.0% |
| Q2 2022 | $3,887,000 | +279.6% | 217,143 | +110.4% | 0.04% | +300.0% |
| Q1 2022 | $1,024,000 | -41.1% | 103,200 | 0.0% | 0.01% | -45.0% |
| Q4 2021 | $1,739,000 | -29.0% | 103,200 | 0.0% | 0.02% | -33.3% |
| Q3 2021 | $2,449,000 | +4.2% | 103,200 | 0.0% | 0.03% | +11.1% |
| Q2 2021 | $2,350,000 | – | 103,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |